SCHEMBL6817533

SCHEMBL6817533

COc1ccc(-c2ccnc(NCCCC3CC3)c2N)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.37
HSP90AB1 P08238 2/20 0.37
KCNH2 Q12809 2/20 0.37
CRHR1 P34998 3/20 0.36
CRHR2 Q13324 1/20 0.36
CDC7 O00311 1/20 0.35
CCNT1 O60563 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35
CSNK1A1 P48729 1/20 0.35
CSNK1D P48730 1/20 0.35
CDK9 P50750 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
DBF4 Q9UBU7 1/20 0.35
HTR1A P08908 3/20 0.34
ADRA1D P25100 3/20 0.34
ADRA1A P35348 3/20 0.34
ADRA1B P35368 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818015 0.96 ACP1 (0.36) HSP90AA1HSP90AB1KCNH2CRHR1CRHR2
SCHEMBL6817674 0.88 CRHR1 (0.36) CRHR1CRHR2CCNT1
SCHEMBL6817777 0.85 BRD4 (0.37) CRHR1HTR1AADRA1DADRA1AADRA1B
SCHEMBL6818255 0.85 CRHR1 (0.36) CRHR1CRHR2CCNT1
SCHEMBL6817664 0.85 KMT5A (0.34) HSP90AA1HSP90AB1CRHR1ACP1KMT5A
SCHEMBL6817843 0.84 SCN9A (0.37) CRHR1CCNT1CDK9ACP1KMT5A
SCHEMBL6813647 0.83 ACP1 (0.43) CRHR1CRHR2CYP1A2CYP3A4CYP2D6
SCHEMBL6817921 0.83 MAPT (0.36) KCNH2CRHR1CRHR2CHRNB2CHRNB4
SCHEMBL6817679 0.83 STK17B (0.35) KMT5A
SCHEMBL6817700 0.80 MAPT (0.35) KCNH2CRHR1CRHR2CHRNB2CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004031189-A1 PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-04-15 WO disclosed